Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Nerv Ment Dis. 2013 May;201(5):414–420. doi: 10.1097/NMD.0b013e31828e0fd6

Table 2.

Means and Standard Deviations of Primary Outcome Variables at Each Assessment for Treatment Completers, Followed by Results of Wilcoxon Signed Rank Sum Tests

Baseline 3 mo. 6 mo. BL to3 mo. 3 mo. to 6 mo.

M (SD) M (SD) M (SD) Mean
Change
d
(95% CIs)
Mean
Change
d
(95% CIs)
PSWQ Total (N = 12) 53.17 (7.94) 48.00 (10.22) 49.67 (13.90) −5.16** .61 (.24, .97) 1.67 .15 (−.16, .46)
ACS (n = 6) 52.67 (8.82) 48.17 (10.76) 45.83 (13.23) −4.50 .43 (−.09, .95) −2.34 .18 (−.18, .54)
Counselor (n = 6) 53.67 (7.76) 47.83 (10.68) 53.50 (14.67) −5.83* .63 (.19, 1.08) 5.67 .45 (−.02, .92)

GADSS Total 14.75 (3.77) 11.58 (4.52) 12.42 (4.96) −3.17* .78 (.10, 1.47) .84 .17 (−.14, .49)
ACS 14.33 (3.98) 12.17 (5.56) 12.17 (4.92) −2.17 .46 (−.09, 1.01) .00 .00 (−.31, .31)
Counselor 15.17 (3.87) 11.00 (3.63) 12.67 (5.47) −4.17 .91 (−.41, 2.22) 1.67 .39 (−.09, .86)

BAI Total 18.83 (7.41) 15.00 (11.50) 13.50 (8.95) −3.83 .48 (−.19, 1.15) −1.5 .12 (−.24, .48)
ACS 19.33 (8.73) 10.50 (7.71) 10.83 (8.52) −8.83 .85 (−.27, 1.98) .33 .04 (−.78, .85)
Counselor 18.33 (6.62) 19.50 (13.52) 16.17 (9.30) 1.16 −.15 (−.83, .53) −3.33 .21 (−.05, .47)

SIGH-A Total 26.33 (8.12) 22.08 (9.41) 22.33 (14.16) −4.25 .49 (.03, .94) .25 .02 (−.47, .52)
ACS 24.33 (6.68) 19.83 (8.73) 21.50 (14.72) −4.50 .57 (−.02, 1.15) 1.67 .16 (−.67, .99)
Counselor 28.33 (9.52) 24.33 (10.33) 23.17 (14.92) −4.00 .35 (−.34, 1.05) −1.16 .10 (−.66, .47)

Note:

**

p <.01,

*

p <.05